Retired HGV driver undergoes heart bypass using gene therapy to reduce risks

Retired HGV driver undergoes heart bypass using gene therapy to reduce risks

The procedure aims to extend the lifespan of blood vessels used during the graft process in the surgery.

Gene therapy trial seeks to reduce coronary graft failure

The first patient has been treated using a novel gene therapy designed to enhance saphenous vein graft (SVG) durability following coronary artery bypass graft (CABG) surgery, as part of a clinical trial aiming to reduce the incidence of graft failure and improve the life expectancy of patients undergoing the procedure. The PROTECT study, a collaboration between NHS Greater Glasgow and the University of Glasgow (both Glasgow, Scotland), investiga…

Organ Swaps and Mass Preventative Gene Therapy to Extend Lifespan

The science of aging and lifespan—often called geroscience—is surrounded by hype and skepticism. Mainstream coverage tends to focus on non-rigorous claims about supplements that extend lifespan in mice or on ideas so extreme they feel ethically and technically out of reach. Just in the past year, the idea of organ swapping and head transplants went from a fiction plotline to a topic being discussed by world leaders caught on a hot mic. Phrasing …